Pfizer Inc. and Pelago annouce that we have entered in to a sub-licensing
Pelago and Biovica announce our collaboration to develop a novel platform
Pelago customer Sprint Bioscience have announced a commercial and collaborative
New commercial and scientific
We announce the new commercial and scientific collaboartion with OmicScouts on CETSA™
CETSA™ inventor Professor Pär Nordlund will present drug discovery
The CETSA™ method is now patented in the US under patent number 8,969,014.